Clinical trial

Pilot Study to Determine Radioiodide Accumulation and Dosimetry in Breast Cancers Using 124I PET/CT

NCT00725946

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2008-02-01

PhaseEARLY_PHASE1

Study timeline

Study start (unknown)2008-02-01Date precision: month

Registry last updated2017-10-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Breast Cancer Early Stage Breast Cancer (Stage 1-3)unresolved

Breast Cancer Metastatic Breast Cancerunresolved

Interventions

Iodine-124DRUG

PET/CT with Iodine-124RADIATION

Sponsors & collaborators

Stanford Universitylead sponsor

Mapped research locations

StanfordCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00725946 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.